Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aakaar Medical TechnologiesNSE:AAKAAR -1.06%20 Days Payable is 23.51 as of Mar. 2026, which is 38% below its 10-year median of 37.82. GuruFocus rates NSE:AAKAAR with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Aakaar Medical Technologies ranks worse than 80.88% on this metric.
The historical rank and industry rank for Aakaar Medical Technologies's Days Payable or its related term are showing as below:
NSE:AAKAAR'
s Days Payable Range Over the Past 10 Years
Min: 33.77 Med: 37.82 Max: 65.04
Current: 33.77
During the past 5 years, Aakaar Medical Technologies's highest Days Payable was 65.04. The lowest was 33.77. And the median was 37.82.
NSE:AAKAAR's Days Payable is ranked worse than 80.88% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs NSE:AAKAAR: 33.77
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:AAKAAR vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Aakaar Medical Technologies's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aakaar Medical Technologies Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aakaar Medical Technologies's Days Payable distribution charts can be found below:
* The bar in red indicates where Aakaar Medical Technologies's Days Payable falls into.
Aakaar Medical Technologies Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aakaar Medical Technologies (NSE:AAKAAR) has a Days Payable of 23.51 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aakaar Medical Technologies and its competitors. This is 38% below median its historical median of 37.82. Over the past decade, Aakaar Medical Technologies' Days Payable has ranged from 33.77 to 65.04. According to the industry distribution chart, Aakaar Medical Technologies ranks #643 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 80.9%.
Is Aakaar Medical Technologies' Days Payable too high?
Aakaar Medical Technologies' current Days Payable of 23.51 is 38% below median its 10-year median of 37.82. Over the past 10 years, this metric has ranged from a low of 33.77 to a high of 65.04. The Medical Devices & Instruments industry median Days Payable is 67.87. Aakaar Medical Technologies' value of 23.51 is 65.4% below this industry median. Based on the distribution chart, Aakaar Medical Technologies ranks #643 out of 795 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Aakaar Medical Technologies has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Aakaar Medical Technologies' Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aakaar Medical Technologies ranks #643 out of 795 companies for Days Payable. This places Aakaar Medical Technologies in the lower half of its industry. The industry median Days Payable is 67.87. Aakaar Medical Technologies' value of 23.51 is 65.4% below this benchmark. Historically, Aakaar Medical Technologies' own Days Payable has ranged from 33.77 to 65.04 over the past decade. While the company's 10-year median is 37.82 vs. the industry median of 67.87, Aakaar Medical Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aakaar Medical Technologies's current Days Payable of 23.51 is 65.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Aakaar Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aakaar Medical Technologies's current Days Payable is 23.51, which is 38% below median its own 10-year median of 37.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aakaar Medical Technologies stock overvalued right now?
Aakaar Medical Technologies (NSE:AAKAAR) has a current Days Payable of 23.51. The current Days Payable is 23.51, which is 38% below median its 10-year median of 37.82 and 65.4% below the Medical Devices & Instruments industry median of 67.87. Aakaar Medical Technologies' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Aakaar Medical Technologies (NSE:AAKAAR), the current Days Payable is 23.51 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aakaar Medical Technologies Ltd is a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. Its product range includes both Own brands (domestically manufactured products & internationally manufactured devices) and Imported Brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It has established a distinctive presence in the medical aesthetic market by exclusively focusing on business-to-business(B2B) channels for product distribution and sales. The company supply its products & devices to dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments.
20GF Score
Get the complete analysis for NSE:AAKAAR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:AAKAAR has been successfully added to your 
